Holen Sie sich die Stockscreener-App
2.00
9.09%
-0.20
Handel nachbörslich:
1.99
-0.01
-0.50%
Schlusskurs vom Vortag:
$2.20
Offen:
$2.1
24-Stunden-Volumen:
144.47K
Relative Volume:
0.89
Marktkapitalisierung:
$44.54M
Einnahmen:
$74,000
Nettoeinkommen (Verlust:
$-13.43M
KGV:
-0.2128
EPS:
-9.4
Netto-Cashflow:
$-10.54M
1W Leistung:
-50.67%
1M Leistung:
-42.24%
6M Leistung:
-66.58%
1J Leistung:
-94.66%
1-Tages-Spanne:
$1.9501
$2.31
1-Wochen-Bereich:
$1.9501
$4.61
52-Wochen-Spanne:
$1.9501
$49.34
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
Firmenname
Cyclacel Pharmaceuticals Inc
Sektor
Branche
Telefon
908-517-7330
Adresse
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Vergleichen Sie CYCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
2.00 | 52.54M | 74,000 | -13.43M | -10.54M | -9.40 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-04-27 | Fortgesetzt | ROTH Capital | Buy |
| 2018-09-07 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-10-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2010-02-04 | Eingeleitet | Roth Capital | Buy |
| 2009-10-28 | Eingeleitet | Merriman | Buy |
| 2008-08-12 | Eingeleitet | Piper Jaffray | Buy |
| 2008-03-12 | Bestätigt | Cantor Fitzgerald | Buy |
| 2008-03-12 | Bestätigt | Collins Stewart | Buy |
| 2008-03-12 | Bestätigt | Needham & Co | Buy |
| 2007-11-27 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-08-10 | Bestätigt | Cantor Fitzgerald | Buy |
| 2007-06-04 | Bestätigt | Needham & Co | Buy |
| 2007-04-23 | Eingeleitet | Lazard Capital | Buy |
| 2007-04-10 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Cyclacel Pharmaceuticals Inc Aktie (CYCC) Neueste Nachrichten
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - The Manila Times
Cyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib Development - Nasdaq
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - GlobeNewswire Inc.
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail
Fitters Clarifies Details Of Business Unit Disposal To Cyclacel - BusinessToday Malaysia
Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Monday - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World
Trend Tracker for (CYCCP) - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shares Scheduled to Reverse Split on Monday, May 12th - Defense World
Cyclacel Pharmaceuticals Announces Reverse Stock Split - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans 1-for-16 Reverse Stock Split | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Announces Stock Split - marketscreener.com
Cyclacel Pharmaceuticals Announces 1-for-16 Reverse Stock Split Effective May 12, 2025 - Nasdaq
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT - The Manila Times
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT | CYCC Stock News - Stock Titan
Cyclacel Pharmaceuticals enters exchange agreement with Fitters - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans Strategic Acquisition and Rebranding | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCH - GuruFocus
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE - The Manila Times
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE - GlobeNewswire
Cyclacel's Major Transformation: 80% Stake in Malaysian Fire Safety Leader Signals Strategic Pivot - Stock Titan
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Stocks of Cyclacel Pharmaceuticals Inc (CYCC) are poised to climb above their peers - Sete News
Press Release Distribution & PR Platform - ACCESS Newswire
Examining Cyclacel Pharmaceuticals Inc (CYCC) more closely is necessary - uspostnews.com
The Psychology of Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: Understanding Market Sentiment - investchronicle.com
Cyclacel Pharmaceuticals (CYCC) Announces Quarterly Dividend - GuruFocus
Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India
Cyclacel Pharmaceuticals expands share authorization - Investing.com
Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel
Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com
StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World
Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com
Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada
Cyclacel Pharmaceuticals announces preferred stock dividend - Investing.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World
When (CYCCP) Moves Investors should Listen - news.stocktradersdaily.com
Cyclacel Pharmaceuticals Inc (CYCC) Q2 2024 Earnings Call Transc - GuruFocus
Fitters Diversified To Dispose Subsidiary To Nasdaq Listed Pharma Firm - BusinessToday Malaysia
Fitters plans to sell full stake in unit to US biotech firm - The Malaysian Reserve
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development - TipRanks
Cyclacel Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift - TipRanks
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results And Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Delays 10-K Filing - TipRanks
CYCC stock touches 52-week low at $0.29 amid sharp annual decline By Investing.com - Investing.com South Africa
Finanzdaten der Cyclacel Pharmaceuticals Inc-Aktie (CYCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):